Diagenode

Chromatin dysregulation associated with NSD1 mutation in head and necksquamous cell carcinoma.


Farhangdoost, Nargess et al.

Chromatin dysregulation has emerged as an important mechanism of oncogenesis. To develop targeted treatments, it is important to understand the transcriptomic consequences of mutations in chromatin modifier genes. Recently, mutations in the histone methyltransferase gene nuclear receptor binding SET domain protein 1 (NSD1) have been identified in a subset of common and deadly head and neck squamous cell carcinomas (HNSCCs). Here, we use genome-wide approaches and genome editing to dissect the downstream effects of loss of NSD1 in HNSCC. We demonstrate that NSD1 mutations are responsible for loss of intergenic H3K36me2 domains, followed by loss of DNA methylation and gain of H3K27me3 in the affected genomic regions. In addition, those regions are enriched in cis-regulatory elements, and subsequent loss of H3K27ac correlates with reduced expression of their target genes. Our analysis identifies genes and pathways affected by the loss of NSD1 and paves the way to further understanding the interplay among chromatin modifications in cancer.

Tags
Antibody
Bioruptor Plus
IP-Star Compact

Share this article

Published
February, 2021

Source

Products used in this publication

  • cut and tag antibody icon
    C15410196
    H3K27ac Antibody - ChIP-seq Grade
  • ChIP kit icon
    C01010051
    iDeal ChIP-seq kit for Histones
  • ChIP kit icon
    C01010171
    Auto iDeal ChIP-seq kit for Histones
  • Bioruptor Plus Sonication Device
    B01020001
    Bioruptor® Plus sonication device

 


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy